Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.38 |
| ▸ | AGTR2 | P50052 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | FEN1 | P39748 | 1/20 | 0.37 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11902719 | 0.91 | SMN1; SMN2 (0.39) | ACHEALDH1A1KDM4EKMT2AMEN1 | |
| SCHEMBL11902809 | 0.82 | ALDH1A1 (0.42) | ACHEALDH1A1KDM4ELMNATDP1 | |
| SCHEMBL11903120 | 0.76 | PPARD (0.38) | ALDH1A1AGTR1AGTR2KMT2AMEN1 | |
| SCHEMBL11903121 | 0.74 | KDM4E (0.36) | ACHEALDH1A1KDM4EAGTR1AGTR2 | |
| SCHEMBL11903090 | 0.74 | ALDH1A1 (0.41) | ACHEALDH1A1KDM4ELMNAKMT2A | |
| SCHEMBL11903055 | 0.68 | HTT (0.42) | ALDH1A1KDM4ELMNAKMT2AMEN1 | |
| SCHEMBL11918131 | 0.67 | ACHE (0.41) | ACHEALDH1A1KDM4ELMNATDP1 | |
| SCHEMBL1609556 | 0.65 | KDM4E (0.43) | ALDH1A1KDM4EKMT2AMEN1SIGMAR1 | |
| SCHEMBL6169361 | 0.65 | AGTR1 (0.58) | AGTR1AGTR2KMT2AMEN1FEN1 | |
| SCHEMBL6170260 | 0.65 | AGTR1 (0.58) | KDM4ETDP1AGTR1AGTR2KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120202690-A1 | HERBICIDAL COMPOUNDS | SYNGENTA LIMITED (US) | 2012-08-09 | — | — | US | disclosed |
| US-20120202690-A1 | HERBICIDAL COMPOUNDS | SYNGENTA LIMITED (US) | 2012-08-09 | — | — | US | disclosed |
| US-20120202690-A1 | HERBICIDAL COMPOUNDS | SYNGENTA LIMITED (US) | 2012-08-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120202690-A1 | HERBICIDAL COMPOUNDS | DDT, HAO2, HAAO | ACHE 225/4885ALDH1A1 718/4885KDM4E 3599/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.